GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

DARE · Jun 30, 2025

Dare Bioscience, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001401914-25-000044General Corporate
Capex intensity75thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

724.52% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

-194.36% · CORE · NOT_ENOUGH_HISTORY

Operating margin100thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.operating_margin

18079.54% · CORE · VALID

SBC intensity0thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

-1695.72% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History9 statesHistory building
Dec 31, 20230/6 normalizedLevel 3Sep 30, 20240/6 normalizedLevel 3Dec 31, 20240/6 normalizedLevel 3Mar 31, 20250/6 normalizedLevel 3Jun 30, 20253/4 normalizedLevel 3Sep 30, 20255/6 normalizedLevel 3Dec 31, 20255/7 normalizedLevel 3Mar 31, 20265/7 normalizedLevel 3Jun 30, 20265/6 normalizedLevel 3
Period transition

What moved in the state?

Capex Intensity Increased
Previous
618.76%
Current
724.52%
Delta
105.77%
Growth Decreased
Previous
173.35%
Current
-194.36%
Delta
-367.71%
Profitability Increased
Previous
-18016.75%
Current
18079.54%
Delta
36096.28%
Sbc Intensity Decreased
Previous
1484.08%
Current
-1695.72%
Delta
-3179.80%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · DARE Fundamental State →Transitioned To · DARE Fundamental State →Transitioned To · DARE CAPEX_INTENSITY_INCREASED →Transitioned To · DARE GROWTH_DECREASED →Transitioned To · DARE PROFITABILITY_INCREASED →Transitioned To · DARE SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.